J. Greer

发表

Nocardial infections in bone marrow transplant recipients.

J. Dummer, R. Stein, S. Goodman, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

M. Bishop, J. Armitage, A. Kessinger, 2000, Bone Marrow Transplantation.

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.

D. Trump, H. Lazarus, H. Fisher, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

J. Fay, D. Reece, C. Lemaistre, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1999, Leukemia & lymphoma.

High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.

H. Lazarus, R. Herzig, R. Stein, 1987, Seminars in oncology.

Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study

J. Lynch, M. Benyunes, R. Herzig, 2001, Bone Marrow Transplantation.

High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin

A. Kallianpur, J. Greer, M. Ahmed, 1999, Bone Marrow Transplantation.

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

R. Collins, J. Fay, J. Lynch, 2000, Bone Marrow Transplantation.

Pulmonary changes in patients with lymphoma who receive paclitaxel.

L. North, F. Cabanillas, A. Younes, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.

W. Dalton, S. Salmon, R. Dorr, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Weekly Intravenous Immunoglobulin to Prevent Infections in Patients Undergoing Autologous Bone Marrow Transplantation or Severe Myelosuppressive Therapy: A Study of the American Bone Marrow Transplant Group

R. Collins, J. Fay, J. Greer, 1993, Annals of Internal Medicine.

Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis

J. Dummer, M. Vusirikala, F. Schuening, 2001, Bone Marrow Transplantation.

High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

J. Whitlock, J. Gay, T. McCurley, 1997, Leukemia.

Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

T. Grogan, W. Dalton, R. Dorr, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1996, Leukemia & lymphoma.

High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1995, Blood.

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.

J. Fay, H. Lazarus, B. Cooper, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma

S. Goodman, T. McCurley, J. Greer, 2000, Bone Marrow Transplantation.

Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.

R. Stein, S. Goodman, S. Wolff, 1995, Bone marrow transplantation.

Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot study.

R. Stein, S. Goodman, S. Wolff, 1996, Leukemia & lymphoma.

Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome.

D. Johnson, F. Greco, A. List, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy.

J. Hainsworth, D. Johnson, F. Greco, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.